Enlighten: An Adaptive Technology Weight Loss Intervention
1 other identifier
interventional
10
1 country
1
Brief Summary
The Enlighten study is an 8-week trial investigating the response to use of a smartphone diet and activity application. Participants are enrolled as part of a worksite intervention, and will receive the LoseIt! weight loss smartphone application, which requires participants to self-monitor dietary intake and physical activity, a component shown to effectively produce weight loss. The application will be programmed to deliver dietary intake recommendations during the first three weeks of the intervention. At the 3 week time point, self-monitoring adherence via the smartphone application will be assessed and those who are not responding will receive 4 weekly telephone coaching sessions. Those individuals who respond at the end of 3 weeks will be encouraged to continue self-monitoring on the application. All participants will also receive regular text messages throughout the trial. The importance of the proposed research lies in the objective to reconfigure weight loss treatment so as to achieve the intended outcome more efficiently and in a manner that allows greater reach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started May 2013
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 10, 2013
CompletedFirst Posted
Study publicly available on registry
May 17, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedSeptember 24, 2013
September 1, 2013
4 months
May 10, 2013
September 20, 2013
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Anthropometric Measures
Weight, Waist Circumference, Blood Pressure
Baseline, 8 Weeks
Self-Monitoring Adherence over Time
Diet,Activity \& Weight Self-Monitoring
Baseline, 8 weeks
Secondary Outcomes (2)
Demographics
Baseline
Call Session Adherence
8 weeks
Study Arms (1)
Technology Supported
EXPERIMENTALInterventions
All participants will complete 8 weeks of recording of dietary intake, weight, and physical activity on a smartphone application. Time-stamped data from the smartphone will upload automatically to the application server, where it will be visible to the lifestyle coach. The participant's real-time diet, activity and weight data relative to their goals will be visually depicted on the participant's smartphone. The coach will monitor participant adherence and send supportive text messages. Response to the application will be assessed 3 weeks after enrollment into the study; measured by number of food items recorded between weeks 1-3 of the intervention; an indicator of use and adherence. Based on adherence, some participants may receive 4 telephone coaching sessions between weeks 5 and 8. Telephone coaching sessions will include feedback on self-monitoring and goal attainment, problem solving, and motivational interviewing.
Eligibility Criteria
You may qualify if:
- BMI greater than 25-39.9 kg/m2
- Weigh no more than 300 pounds.
- Weight stable (no loss or gain \>25 lbs for the past 6 months)
- Not enrolled in any formal weight loss program
- Not currently taking anti-obesity medications
- Interested in losing weight
- Own an Android Smartphone or iPhone, be willing to install the Lose It! Application, and agree to join the Enlighten group which will allow study staff to view participant data using a private coaching interface.
You may not qualify if:
- Unstable medical conditions (uncontrolled hypertension, diabetes, unstable angina pectoris, myocardial infarction, transient ischemic attack, cancer undergoing active treatment, or cerebrovascular accident within the past six months)
- History of diabetes requiring insulin supplementation
- Crohn's Disease
- Diagnosis of obstructive sleep apnea requiring intervention (i.e. CPAP)
- Require use of an assistive device for mobility (e.g., wheelchair, walker, cane)
- BMI greater than or equal to 40, weight greater than or equal to 300 pounds
- Hospitalization for a psychiatric disorder within the past 5 years
- Those at risk for adverse cardiovascular (CVD) events with moderate intensity activity
- Those who cannot read the study questionnaires will be excluded
- Those currently taking weight loss medication or committed to following an incompatible dietary regimen.
- Female participants may not be pregnant, trying to get pregnant, or lactating.
- Bulimia Nervosa
- Binge Eating Disorder
- Active Suicidal Ideation
- those on medications known to cause weight gain (e.g., prednisone)
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bonnie J Spring, PhD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 10, 2013
First Posted
May 17, 2013
Study Start
May 1, 2013
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
September 24, 2013
Record last verified: 2013-09